ELTX

1.4503.33%
CM

Christopher M. Haqq

Executive VP, Head of Research & Development and Chief Medical Officer

Dr. Christopher M. Haqq, M.D., Ph.D., also known as Chris, serves as Executive Vice President, Head of Research & Development and Chief Medical Officer at Elicio Therapeutics since October 2019. He had been Chief Scientific Officer and Executive Vice President of R&D at Atara Biotherapeutics, Inc. since September 2012 until October 2019 and served as its Chief Medical Officer since September 2012. Dr. Haqq served as Vice President of Clinical Research & Development of Cougar Biotechnology, Inc. Dr. Haqq has clinical and translational research experience in oncology. He serves as Independent Director at Consonance-HFW Acquisition Corp since 2020. Dr. Haqq joined Cougar Biotechnology, Inc. in March 2007 and served as its Senior Director of Clinical Research and Development since May 2007. From 2005 to March 2007, Dr. Haqq was employed by Amgen Inc., where he led the Early Development Oncology Group. In that role, he successfully recruited and managed a team of M.D. and M.D./Ph.D. clinical scientists for Amgen's Phase I and Phase II oncology product candidates. He served as an attending Urologic Oncologist at the UCSF Prostate Cancer Center. Dr. Haqq has worked closely with the US Food and Drug Administration, or the FDA and other global regulatory agencies. Dr. Haqq initially practiced as a medical oncologist and led a translational science laboratory as an Assistant Professor in the Division of Hematology/Oncology at the University of California, San Francisco following his post-graduate training as an Intern and Resident in Internal Medicine, Fellow in Medical Oncology and Fellow in Molecular Medicine. He received his M.D. and Ph.D. degrees in Genetics from Harvard Medical School in 1996. He received a B.S. from Stanford University and completed his undergraduate training at University of British Columbia. Dr. Haqq completed his Residency in Internal Medicine and Fellowships in Medical Oncology and Molecular Medicine at UCSF.

Positions